Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 20.30
-0.06 (-0.29%)
Oct 23, 2026, 5:30 PM CEST
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 807.06 million as of October 23, 2026. It is the 10,049th most valuable company in the world and the 122nd biggest in Switzerland. Its market cap has decreased by 35.06% in one year.
Market Cap
807.06M
Enterprise Value
807.33M
Revenue
141.35M
Global Rank
Country Rank
#122 Switzerland
PE Ratio
115.36
ChartMarket Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 807.06M, a decrease of -75.16%. That is a compound annual growth rate of -12.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 807.06M | -24.99% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 311.26B |
| Novartis AG | 240.44B |
| Lonza Group AG | 43.65B |
| Galderma Group AG | 40.81B |
| PolyPeptide Group AG | 1.45B |
| Aevis Victoria | 1.23B |
| Idorsia | 1.14B |
| Medartis Holding AG | 1.09B |